Code

AZGS2025122

Naam

(ENLIGHTEN-6)

Omschrijving

A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Once Weekly Eloralintide in Adult Participants with Persistent Obesity or Overweight Treated with a Weekly Incretin, with and without Type 2 Diabetes (ENLIGHTEN-6)

Start inclusieperiode

1-6-2026

Einde inclusieperiode

1-12-2026

Algemeen

Contact